• Explore /
  • Poster
  • / Randomized phase III study of adjuvant versus progression-triggered treatment with gemcitabine (G) after radical cystectomy (RC) for locally advanced bladder cancer (LABC) in patients not suitable for cisplatin-based chemotherapy (CBC) (AUO-trial AB22/00).

Randomized phase III study of adjuvant versus progression-triggered treatment with gemcitabine (G) after radical cystectomy (RC) for locally advanced bladder cancer (LABC) in patients not suitable for cisplatin-based chemotherapy (CBC) (AUO-trial AB22/00).

Abstract Poster

Authors

Jan Lehmann

Jan Lehmann

Department of Urology, Saarland University, Homburg/Saar, Germany

Jan Lehmann , Michael Kuehn , Claus Fischer , Bjoern Volkmer , Friedrich von Rundstedt , Peter Albers , Eduard Becht , Andreas Bannowsky , Rainer Hofmann , Sigrun Langbein , Margitta Retz , Michael Stoeckle

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT00146276

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 250)

DOI

10.1200/jco.2013.31.6_suppl.250

Abstract #

250

Poster Bd #

A5

Abstract Disclosures

Similar Posters

First Author: Mohamed S. Zaghloul

First Author: Mohamed S. Zaghloul

First Author: Matt D. Galsky

First Author: Christian Pfister